CIK 0001228627
- Non-accelerated filer
- Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113516358
- Phone
- +1 984-884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 1,893 shares (grant or award)
- 4 Grant or award Director acquired 2,581 shares (grant or award)
- 4 Open-market buy Director bought 4,434 shares
- 4 Open-market buy Director bought 17,730 shares
- 4 Open-market buy Director bought 8,865 shares
- 4 Open-market buy Director bought 1,771 shares
- 4 Open-market buy Director bought 8,865 shares
- 4 Open-market buy President and CEO bought 11,524 shares
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 485,258 shares (grant or award)
Page 10 of 21 · 403 filings